Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

121.55 -1.50 (-1.22%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? ↗

May 03, 2024

Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.

Via InvestorPlace

DaVita (DVA) Q1 2024 Earnings Call Transcript ↗

May 02, 2024

DVA earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 ↗

May 01, 2024

Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.

Via InvestorPlace

Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now? ↗

April 27, 2024

These high-flying Buffett stocks could be attractive to different kinds of investors.

Via The Motley Fool

Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses ↗

April 22, 2024

Ford, United Airlines and megacap AI stock Nvidia were big-cap winners.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session

March 05, 2024

Via Investor Brand Network

DaVita Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗

February 20, 2024

Via Benzinga

How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher ↗

April 18, 2024

ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.

Via Investor's Business Daily

The Best Warren Buffett Stocks to Buy With $300 Right Now ↗

April 11, 2024

Even with $300, many Buffett investments are within reach of the average investor.

Via The Motley Fool

3 Soaring, Highly-Ranked Value Stocks To Buy In April ↗

April 06, 2024

The stock market bounced back on Wednesday and looked strong through morning trading Thursday until sellers showed up.

Via Talk Markets

3 High-Dividend ETFs That Could Be Smart Investments Right Now ↗

April 04, 2024

These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own.

Via The Motley Fool

Topics Bonds ETFs

Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them) ↗

March 24, 2024

Berkshire even lists one of these companies as a subsidiary.

Via The Motley Fool

Why DaVita Stock Popped Today ↗

February 14, 2024

The dialysis services company handily beat expectations with its latest quarter.

Via The Motley Fool

DaVita: Q4 Earnings Insights ↗

February 13, 2024

Via Benzinga

DaVita Earnings Preview ↗

February 12, 2024

Via Benzinga

3 No-Brainer Warren Buffett Stocks to Buy Right Now ↗

March 19, 2024

Strong brands and market presence make these three companies attractive investments.

Via The Motley Fool

Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗

March 05, 2024

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks

Via Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday ↗

March 05, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News ↗

March 05, 2024

Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.

Via Investor's Business Daily

3 Cheap Stocks to Buy Now for Fast Gains ↗

February 22, 2024

Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth.

Via InvestorPlace

Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details ↗

February 20, 2024

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

Via Benzinga

3 Top-Rated Stocks To Buy After Comfortably Surpassing Earnings Expectations ↗

February 16, 2024

This week’s earnings lineup has featured several top-rated stocks that have added to this optimistic growth narrative and here are a few to consider

Via Talk Markets

Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday ↗

February 14, 2024

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

DaVita (DVA) Q4 2023 Earnings Call Transcript ↗

February 13, 2024

DVA earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Time To Buy These High Growth Stocks As Earnings Approach ↗

February 13, 2024

This week’s earnings lineup will be highlighted by several growth stocks with none standing out more than Airbnb and DaVita

Via Talk Markets

Meet the Most Ridiculously Cheap Stock in Warren Buffett's Berkshire Hathaway Portfolio ↗

February 12, 2024

This stock isn't cheap because it's performed poorly over the past 12 months.

Via The Motley Fool

Earnings Scheduled For February 13, 2024 ↗

February 13, 2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

Via Benzinga

2 Best Warren Buffett Stocks to Buy for the Long Haul ↗

February 09, 2024

You don't need to have millions of dollars to invest in quality businesses.

Via The Motley Fool

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DaVita HealthCare Partner (NY:DVA)

All News about DaVita HealthCare Partner

Starting at $3.75/week.

Subscribe Today